INZY

Inozyme Pharma
INZY

Overview Fund Activity
Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

80 hedge funds and large institutions have $214M invested in Inozyme Pharma in 2023 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 15 reducing their positions, and 9 closing their positions.

Holders
80
Holders Change
+3
Holders Change %
+3.9%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
13
Increased
42
Reduced
15
Closed
9
Calls
$1.44M
Puts
$100K
Net Calls
+$1.34M
Net Calls Change
+$891K

Top Buyers

1
BOCH
1
Blue Owl Capital Holdings
New York
$5.41M
2
BlackRock
2
BlackRock
New York
$13M
3
AAA
3
Affinity Asset Advisors
New York
$8.03M
4
SFM
4
Sphera Funds Management
Israel
$6.66M
5
Goldman Sachs
5
Goldman Sachs
New York
$1.55M

Top Sellers

1
OCA
1
Octagon Capital Advisors
New York
$1.7M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$0
3
Millennium Management
3
Millennium Management
New York
$3.88M
4
SSA
4
Schonfeld Strategic Advisors
New York
$463K
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$9.68M
Name Holding Trade Value Shares
Change 		Shares
Change %
UOC
26
UBS O'Connor
Illinois
$1.04M +$382K +89,623 +58%
Morgan Stanley
27
Morgan Stanley
New York
$984K +$872K +204,588 +776%
OMC
28
Overbrook Management Corp
New York
$934K – – –
Renaissance Technologies
29
Renaissance Technologies
New York
$931K -$329K -77,108 -26%
PHP
30
Parkman Healthcare Partners
Connecticut
$905K +$156K +36,536 +21%
GCP
31
GSA Capital Partners
United Kingdom
$711K +$317K +74,358 +80%
Nuveen Asset Management
32
Nuveen Asset Management
Illinois
$685K +$98.5K +23,130 +17%
Citadel Advisors
33
Citadel Advisors
Florida
$679K +$108K +25,453 +19%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$673K +$71.9K +16,874 +12%
SCM
35
Superstring Capital Management
New York
$528K +$528K +123,944 New
Charles Schwab
36
Charles Schwab
California
$518K +$118K +27,655 +29%
SSA
37
Schonfeld Strategic Advisors
New York
$463K -$866K -203,180 -65%
Bank of America
38
Bank of America
North Carolina
$314K -$80.6K -18,928 -20%
Two Sigma Advisers
39
Two Sigma Advisers
New York
$301K -$108K -25,400 -26%
Barclays
40
Barclays
United Kingdom
$295K +$256K +59,904 +650%
Dimensional Fund Advisors
41
Dimensional Fund Advisors
Texas
$272K +$18.1K +4,244 +7%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$257K +$61.2K +14,365 +31%
Two Sigma Investments
43
Two Sigma Investments
New York
$229K -$61.3K -14,400 -21%
BCM
44
Bridgeway Capital Management
Texas
$221K -$170K -39,883 -44%
Jane Street
45
Jane Street
New York
$219K +$219K +51,404 New
UBS Group
46
UBS Group
Switzerland
$197K +$116K +27,290 +144%
AQR Capital Management
47
AQR Capital Management
Connecticut
$196K +$111K +26,169 +133%
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$186K +$186K +43,657 New
AA
49
ALPS Advisors
Colorado
$180K +$180K +42,215 New
BC
50
BIT Capital
Germany
$161K +$37.1K +8,708 +30%
1
2
3 4